FDAClass IFebruary 8, 2023

CADD Administration Set recall

CADD Administration Set, List Numbers: 1) REF 21-7300-24, 2) REF 21-7301-24 3) REF 21-7302-24, 4) REF 21-7321-24, 5) REF 21-7322-24, 6) REF…

Why was CADD Administration Set recalled?

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

1) REF 21-7300-24, UDI/DI 30610586027196, Lot numbers: 3630772 through 4334107; 2) REF 21-7301-24, UDI/DI 30610586027219, Lot numbers: 3630747 through 4334119; 3) REF 21-7302-24, UDI/DI 30610586027233, Lot numbers: 3617363 through 4334138; 4) REF 21-7321-24, UDI/DI 30610586029633, Lot numbers: 3773534 through 4308545; 5) REF 21-7322-24, UDI/DI 30610586029640, Lot numbers: 3776375 through 4334324; 6) REF 21-7323-24, UDI/DI 061058603961, Lot numbers: 3776373 through 4334325; 7) REF 21-7324-24, UDI/DI 30610586029657, Lot numbers: 3773527 through 4334328; 8) REF 21-7333-24, UDI/DI 30610586043233, Lot numbers: 3776362 through 3984144; 9) REF 21-7336-24, UDI/DI 30610586027295, Lot numbers: 3776360 through 4025381; 10) REF 21-7339-24, UDI/DI 30610586027301, Lot numbers: 3780565 through 4009665; 11) REF 21-7343-24, UDI/DI 35019517191824, Lot numbers: 3965344 through 4334338; 12) REF 21-7349-24, UDI/DI 35019517184239, Lot numbers: 3926579 through 4339160; 13) REF 21-7359-24, UDI/DI 30610586027400, Lot numbers: 3776315 through 4334339; 14) REF 21-7383-24, UDI/DI 30610586027479, Lot numbers: 3780549 through 3971523; 15) REF 21-7390-24, UDI/DI 30610586027509, Lot numbers: 3780548 through 4334346; 16) REF 21-7391-24, UDI/DI 30610586027516, Lot numbers: 3773276 through 4334351; 17) REF 21-7394-24, UDI/DI 30610586027530, Lot numbers: 3774739 through 4339178; 18) REF 21-7395-24, UDI/DI 30610586027547, Lot numbers: 3808536 through 4308562 19) REF 21-7301-24JP, UDI/DI N/A , Lot numbers: 3630747 through 4334113; 20) REF 21-7302-24JP, UDI/DI N/A , Lot numbers: 3617363 through 4329630; 21) REF 21-7321-24JP, UDI/DI N/A , Lot numbers: 3773534 through 4308545; 22) REF 21-7322-24JP, UDI/DI N/A , Lot numbers: 3776375 through 4334324; 23) REF 21-7359-24JP, UDI/DI N/A , Lot numbers: 3776315 through 4334339; 24) REF 21-7394-24JP, UDI/DI N/A , Lot numbers: 3774739 through 4339178.

Product
CADD Administration Set, List Numbers: 1) REF 21-7300-24, 2) REF 21-7301-24 3) REF 21-7302-24, 4) REF 21-7321-24, 5) REF 21-7322-24, 6) REF…
Recalling firm
Smiths Medical ASD Inc.
Quantity
45285351 units
Distribution
Worldwide Distribution: US (nationwide) and OUS countries of: CH, CA, ES, FR, AT, BE, IT, DK, NO, EE, DE, NL, AU, GB, SE, PL, SA, IN, IL, PT, CZ, IE, NZ, LU, SI, ZA, BM, SG, MQ, CL, LB, MY, HU, JP, TW, and CN
Recall date
February 8, 2023
Classification
Class I
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls